Xenon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Revenue	0	9.43	18.44	32.17	6.83	0	0.31	1.8	15.58	28.37	Upgrade
Revenue Growth (YoY)	-	-48.83%	-42.68%	371.02%	-	-	-82.75%	-88.43%	-45.09%	3.71%	Upgrade
Gross Profit	0	9.43	18.44	32.17	6.83	0	0.31	1.8	15.58	28.37	Upgrade
Selling, General & Admin	46.54	32.81	21.97	12.94	10.8	8.41	7.31	6.79	9.79	5.5	Upgrade
Research & Development	167.51	105.77	75.46	50.52	38.85	23.63	25.57	19.83	15.15	11.77	Upgrade
Other Operating Expenses	0	0	0	0	0	6	0	0	0	0	Upgrade
Operating Expenses	214.05	138.58	97.43	63.47	49.65	38.04	32.89	26.62	24.94	17.26	Upgrade
Operating Income	-214.05	-129.14	-78.99	-31.3	-42.82	-38.04	-32.58	-24.82	-9.36	11.11	Upgrade
Interest Expense / Income	0	0	0	0.48	1.43	1.39	0	0	0	0	Upgrade
Other Expense / Income	-31.37	-3.89	-0.11	-2.69	-2.64	-4.91	-1.87	-1.82	6.39	-1.91	Upgrade
Pretax Income	-182.69	-125.26	-78.89	-29.09	-41.62	-34.52	-30.7	-23	-15.75	13.02	Upgrade
Income Tax	-0.29	0.12	-0.01	-0.26	-0.02	-0.02	0	0	0	0	Upgrade
Net Income	-182.39	-125.37	-78.88	-28.84	-41.6	-34.5	-30.7	-23	-15.75	13.02	Upgrade
Preferred Dividends	0	-0.44	-1.8	-0.82	-1.57	-2.88	0	0	0	0	Upgrade
Net Income Common	-182.39	-124.94	-77.09	-28.01	-40.03	-31.62	-30.7	-23	-15.75	13.02	Upgrade
Net Income Growth	-	-	-	-	-	-	-	-	-	239.63%	Upgrade
Shares Outstanding (Basic)	67	61	44	35	26	19	18	15	14	3	Upgrade
Shares Outstanding (Diluted)	67	61	44	35	26	19	18	15	14	4	Upgrade
Shares Change	10.48%	38.77%	26.30%	33.17%	33.53%	7.91%	16.19%	8.48%	260.31%	97.29%	Upgrade
EPS (Basic)	-2.73	-2.06	-1.77	-0.81	-1.54	-1.63	-1.71	-1.48	-1.10	4.11	Upgrade
EPS (Diluted)	-2.73	-2.06	-1.77	-0.81	-1.54	-1.63	-1.72	-1.48	-1.10	3.28	Upgrade
EPS Growth	-	-	-	-	-	-	-	-	-	71.73%	Upgrade
Free Cash Flow	-150.94	-101.32	-71.55	-50.76	-5.95	-35.23	-29.04	-19.85	-18.65	-1.26	Upgrade
Free Cash Flow Per Share	-2.26	-1.67	-1.64	-1.47	-0.23	-1.81	-1.61	-1.28	-1.31	-0.40	Upgrade
Gross Margin	-	100.00%	100.00%	100.00%	100.00%	-	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-1368.91%	-428.45%	-97.31%	-627.02%	-	-10474.28%	-1376.43%	-60.10%	39.15%	Upgrade
Profit Margin	-	-1324.32%	-418.11%	-87.09%	-586.13%	-	-9872.67%	-1275.49%	-101.12%	45.89%	Upgrade
Free Cash Flow Margin	-	-1074.03%	-388.09%	-157.81%	-87.19%	-	-9337.94%	-1100.72%	-119.75%	-4.45%	Upgrade
EBITDA	-179.14	-123.63	-77.98	-27.97	-39.76	-32.54	-30.06	-22.13	-14.71	13.76	Upgrade
EBITDA Margin	-	-1310.48%	-422.96%	-86.94%	-582.15%	-	-9663.99%	-1227.57%	-94.46%	48.49%	Upgrade
Depreciation & Amortization	3.54	1.62	0.91	0.64	0.43	0.59	0.65	0.86	1.04	0.74	Upgrade
EBIT	-182.69	-125.26	-78.89	-28.61	-40.18	-33.13	-30.7	-23	-15.75	13.02	Upgrade
EBIT Margin	-	-1327.70%	-427.88%	-88.94%	-588.43%	-	-9872.67%	-1275.49%	-101.12%	45.89%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).